Literature DB >> 11950728

Arthritis drug should be removed from market, says consumer group.

Fred Charatan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11950728      PMCID： PMC1122826          DOI： 10.1136/bmj.324.7342.869/a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

Review 1.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.